Crux Biotech India Private Limited, a active private limited company, was established on 20 May 2010 in Hyderabad, Telangana, India. Engaging in alcoholic beverage manufacturing & distribution within the manufacturing sector, it holds CIN: U24296TG2010PTC068519. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹54.50 Cr and a paid-up capital of ₹52.05 Cr.
It upholds a active non-compliant status. Employing 162 professional, Its leadership includes Venkata Reddy Vemireddy (Director), Sivakumar Reddy Munnangi (Director), Subba Reddy Munnangi (Director). Past directors included Ravichandra Gogineni, Gudibandi Lenin. It holds ₹357.16 Cr open charges and ₹92.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 8-3-222/C/1, A-26, Madhura Nagar Ameerpet, Hyderabad, Telangana, 500038.
U24296TG2010PTC068519
068519
20 May 2010
₹54.50 Cr
₹52.05 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Crux Biotech India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkata Reddy Vemireddy | Director | 21 Oct 2010 | Current |
| Sivakumar Reddy Munnangi | Director | 21 Oct 2010 | Current |
| Subba Reddy Munnangi | Director | 21 Oct 2010 | Current |
| Srinivasa Reddy Vuyyuru | Director | 16 Mar 2015 | Current |
| Ravichandra Gogineni | Managing Director | 20 May 2010 | Current |
| Gadi Chandra Sekhar Reddy | Director | 20 May 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Sep 2013 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Crux Biotech India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.11% increase. The company also saw a substantial improvement in profitability, with a 11.01% increase in profit. The company's net worth moved up by a moderate rise of 2.34%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Crux Biotech India had a promoter holding of 20.86% and a public holding of 79.14%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,571,593,280.00
₹925,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Nov 2024 | Others | ₹9.00 M | Open |
| 30 Mar 2024 | Hdfc Bank Limited | ₹1.02 Cr | Open |
| 12 Mar 2024 | Others | ₹12.92 Cr | Open |
| 27 Oct 2023 | Sbicap Trustee Company Limited | ₹289.10 Cr | Open |
| 03 Feb 2023 | Hdfc Bank Limited | ₹4.16 M | Open |
Explore comprehensive loan charge details -
Crux Biotech India has a workforce of 162 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Crux Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crux Biotech India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Sbicap Trustee Company Limited of Rs. 289.10 Cr registered on 27 Oct 2023 with Charge ID 100815271 was modified on 28 Aug 2025. was completed.
A charge with Hdfc Bank Limited of Rs. 50.00 Cr registered on 01 Jun 2018 with Charge ID 100185561 was modified on 21 Aug 2025. was recorded as a recent event.
Progress on A charge registered on 15 Jun 2019 via Charge ID 100270701 with Others was fully satisfied on 20 Aug 2025. was documented.
A charge with Others of Rs. 12.92 Cr registered on 12 Mar 2024 with Charge ID 100916374 was modified on 31 May 2025. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 0.90 Cr with Charge ID 101001978 was registered on 07 Nov 2024. was documented.
The activity Crux Biotech India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The CIN of Crux Biotech India Private Limited is U24296TG2010PTC068519.
Crux Biotech India Private Limited is headquartered at 8-3-222/C/1, A-26, Madhura Nagar Ameerpet, Hyderabad, Telangana, 500038.
Crux Biotech India Private Limited was incorporated on 20 May 2010.
The current directors of Crux Biotech India Private Limited are
The primary industry of Crux Biotech India Private Limited is Manufacturing.
Crux Biotech India Private Limited is unlisted.
The authorized capital of Crux Biotech India Private Limited is ₹54.50 Cr, and the paid-up capital is ₹52.05 Cr.
The compliance status of Crux Biotech India Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX